I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 5 studies | 35% ± 22% | |
| naive thymus-derived CD8-positive, alpha-beta T cell | 4 studies | 18% ± 2% | |
| CD4-positive, alpha-beta T cell | 4 studies | 17% ± 2% | |
| T cell | 3 studies | 27% ± 13% | |
| natural killer cell | 3 studies | 18% ± 2% | |
| mucosal invariant T cell | 3 studies | 18% ± 2% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 17% ± 2% | |
| endothelial cell | 3 studies | 24% ± 2% | |
| CD8-positive, alpha-beta memory T cell | 3 studies | 18% ± 1% | |
| gamma-delta T cell | 3 studies | 27% ± 9% |
